The current and future status of critical care testing and patient monitoring

Gerald J Kost, C. Hague

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Ex vivo and in vivo biosensor-based systems for patient monitoring now augment in vitro point-of-care testing, a paradigm currently in the explosive phase. As new technologies arise, so do opportunities for laboratory professionals. First, the laboratory consultant or clinical pathologist can contribute substantially to our understanding of temporal optimization and the role of diagnostic testing in optimizing diagnostic-therapeutic processes. Clarification of these facilitates wise selection of alternative testing modalities, test clusters, and instrument formats. Second, the laboratory professional is a natural member of a performance team that can help optimize outcomes and assure the quality of point-of-care testing. Explicit site-specific performance criteria for accuracy, precision, response time, and test clusters are essential and can only be established and accomplished jointly with clinicians. Third, clinical integration requires practice guidelines and care paths. These can help determine how, when, and where point-of-care testing should be implemented. Finally, global outcomes optimization calls for the input of those professionals who are most familiar with the economics of diagnostic testing, the challenges of point-of-care testing, and the best clinical benefits of in vitro, ex vivo, and in vivo biosensor-based systems in critical care and other settings.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Pathology
Volume104
Issue number4 SUPPL. 1
StatePublished - 1995

Fingerprint

Physiologic Monitoring
Critical Care
Biosensing Techniques
Quality of Health Care
Consultants
Practice Guidelines
Reaction Time
Economics
Technology
Point-of-Care Testing
In Vitro Techniques
Therapeutics

Keywords

  • Biosensors
  • Critical care profile
  • Hybridization
  • Ionized calcium
  • Knowledge optimization
  • Outcomes optimization
  • Patient focusing
  • Patient monitoring
  • Point- of-care testing
  • Test clusters
  • Whole blood analysis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The current and future status of critical care testing and patient monitoring. / Kost, Gerald J; Hague, C.

In: American Journal of Clinical Pathology, Vol. 104, No. 4 SUPPL. 1, 1995.

Research output: Contribution to journalArticle

@article{6fa0ab8cea0e4e2a8cae409bc89d5c43,
title = "The current and future status of critical care testing and patient monitoring",
abstract = "Ex vivo and in vivo biosensor-based systems for patient monitoring now augment in vitro point-of-care testing, a paradigm currently in the explosive phase. As new technologies arise, so do opportunities for laboratory professionals. First, the laboratory consultant or clinical pathologist can contribute substantially to our understanding of temporal optimization and the role of diagnostic testing in optimizing diagnostic-therapeutic processes. Clarification of these facilitates wise selection of alternative testing modalities, test clusters, and instrument formats. Second, the laboratory professional is a natural member of a performance team that can help optimize outcomes and assure the quality of point-of-care testing. Explicit site-specific performance criteria for accuracy, precision, response time, and test clusters are essential and can only be established and accomplished jointly with clinicians. Third, clinical integration requires practice guidelines and care paths. These can help determine how, when, and where point-of-care testing should be implemented. Finally, global outcomes optimization calls for the input of those professionals who are most familiar with the economics of diagnostic testing, the challenges of point-of-care testing, and the best clinical benefits of in vitro, ex vivo, and in vivo biosensor-based systems in critical care and other settings.",
keywords = "Biosensors, Critical care profile, Hybridization, Ionized calcium, Knowledge optimization, Outcomes optimization, Patient focusing, Patient monitoring, Point- of-care testing, Test clusters, Whole blood analysis",
author = "Kost, {Gerald J} and C. Hague",
year = "1995",
language = "English (US)",
volume = "104",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4 SUPPL. 1",

}

TY - JOUR

T1 - The current and future status of critical care testing and patient monitoring

AU - Kost, Gerald J

AU - Hague, C.

PY - 1995

Y1 - 1995

N2 - Ex vivo and in vivo biosensor-based systems for patient monitoring now augment in vitro point-of-care testing, a paradigm currently in the explosive phase. As new technologies arise, so do opportunities for laboratory professionals. First, the laboratory consultant or clinical pathologist can contribute substantially to our understanding of temporal optimization and the role of diagnostic testing in optimizing diagnostic-therapeutic processes. Clarification of these facilitates wise selection of alternative testing modalities, test clusters, and instrument formats. Second, the laboratory professional is a natural member of a performance team that can help optimize outcomes and assure the quality of point-of-care testing. Explicit site-specific performance criteria for accuracy, precision, response time, and test clusters are essential and can only be established and accomplished jointly with clinicians. Third, clinical integration requires practice guidelines and care paths. These can help determine how, when, and where point-of-care testing should be implemented. Finally, global outcomes optimization calls for the input of those professionals who are most familiar with the economics of diagnostic testing, the challenges of point-of-care testing, and the best clinical benefits of in vitro, ex vivo, and in vivo biosensor-based systems in critical care and other settings.

AB - Ex vivo and in vivo biosensor-based systems for patient monitoring now augment in vitro point-of-care testing, a paradigm currently in the explosive phase. As new technologies arise, so do opportunities for laboratory professionals. First, the laboratory consultant or clinical pathologist can contribute substantially to our understanding of temporal optimization and the role of diagnostic testing in optimizing diagnostic-therapeutic processes. Clarification of these facilitates wise selection of alternative testing modalities, test clusters, and instrument formats. Second, the laboratory professional is a natural member of a performance team that can help optimize outcomes and assure the quality of point-of-care testing. Explicit site-specific performance criteria for accuracy, precision, response time, and test clusters are essential and can only be established and accomplished jointly with clinicians. Third, clinical integration requires practice guidelines and care paths. These can help determine how, when, and where point-of-care testing should be implemented. Finally, global outcomes optimization calls for the input of those professionals who are most familiar with the economics of diagnostic testing, the challenges of point-of-care testing, and the best clinical benefits of in vitro, ex vivo, and in vivo biosensor-based systems in critical care and other settings.

KW - Biosensors

KW - Critical care profile

KW - Hybridization

KW - Ionized calcium

KW - Knowledge optimization

KW - Outcomes optimization

KW - Patient focusing

KW - Patient monitoring

KW - Point- of-care testing

KW - Test clusters

KW - Whole blood analysis

UR - http://www.scopus.com/inward/record.url?scp=0028800890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028800890&partnerID=8YFLogxK

M3 - Article

C2 - 7484945

AN - SCOPUS:0028800890

VL - 104

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4 SUPPL. 1

ER -